The compound profile of Chrysanthemum cinerariifolium (Trev.) extract and its potential in inhibiting COX-2 and CDK-4/6 receptors in Oral Squamous Cell Carcinoma (OSCC) (In silico study)

Listiyana, Anik ORCID: https://orcid.org/0000-0001-6476-2977, Mutiah, Roihatul ORCID: https://orcid.org/0000-0002-8196-9029, Yueniwati, Yuyun ORCID: https://orcid.org/0000-0001-9932-2015, Astari, Lina Fitria ORCID: https://orcid.org/0000-0003-4777-5092, Indradmojo, Christyaji ORCID: https://orcid.org/0000-0002-5559-8068 and Suroso, Niertara Awliya (2025) The compound profile of Chrysanthemum cinerariifolium (Trev.) extract and its potential in inhibiting COX-2 and CDK-4/6 receptors in Oral Squamous Cell Carcinoma (OSCC) (In silico study). Journal of Islamic Medicine, 9 (2). pp. 1-12. ISSN 2550-0074

Preview

Text 24491.pdf - Published Version Available under License Creative Commons Attribution Share Alike. Download (752kB) | Preview

Abstract

Cancer is a disease that appears characterized by abnormal cell growth which can then infect adjoining parts of the body and or spread to other organs. One type of cancer that often occurs is Oral Squamous Cell Carcinoma (OSCC). There are several target receptors involved in cell proliferation, which are COX-2 and CDK-4/6 receptors. One of the herbal treatments for OSCC can be done using Chrsanthemum cinerariifolium Trev.) herb extract. This research aims to find active compounds in hrysanthemum cinerariifolium (Trev.) using UPLC-QToF-MS/MS method, the analysis of physiochemical prediction, toxicity analysis and molecular docking results on the proteins of COX-2 and CDK-4/6. This research combines two types of research, which are descriptive experimental for metabolite analysis and preexperimental one shot case study type for in silico test. The analysis of Metabolite compounds is using UPLC-QToFMS/MS Instrumentation, and for in silico tests using some SwissADME for physiochemical tests, PkCSM and Protox Online Tools for toxicity tests and Biovia Discovery Studio Visualizer and PyRx 0.8 for molecular docking tests. The results of this study obtained 28 compounds from metabolite profiling. And the results of molecular docking showed 1 compound with the best affinity on the tethering of both receptors. The compound is Diosmetin. There are also amino acid with 15 residues obtained in this process. However, the bonding value of native ligand with target protein is higher than the bonding of test ligand with target protein.

Item Type:	Journal Article
Keywords:	Chrysanthemum cinerariifolium (Trev.); Metabolite Profiling; Molecular Docking; Oral Squamous Cell Carcinoma
Subjects:	11 MEDICAL AND HEALTH SCIENCES > 1105 Dentistry > 110505 Oral Medicine and Pathology 11 MEDICAL AND HEALTH SCIENCES > 1105 Dentistry > 110599 Dentistry not elsewhere classified 11 MEDICAL AND HEALTH SCIENCES > 1112 Oncology and Carcinogenesis > 111204 Cancer Therapy (excl. Chemotherapy and Radiation Therapy) 11 MEDICAL AND HEALTH SCIENCES > 1112 Oncology and Carcinogenesis > 111205 Chemotherapy 11 MEDICAL AND HEALTH SCIENCES > 1112 Oncology and Carcinogenesis > 111207 Molecular Targets 11 MEDICAL AND HEALTH SCIENCES > 1115 Pharmacology and Pharmaceutical Sciences > 111599 Pharmacology and Pharmaceutical Sciences not elsewhere classified 11 MEDICAL AND HEALTH SCIENCES > 1112 Oncology and Carcinogenesis
Divisions:	Faculty of Medical and Health Sciences > Department of Medical Education
Depositing User:	Anik Listiyana
Date Deposited:	08 Oct 2025 14:12

Downloads

Origin of downloads

Actions (login required)

View Item